Privacy Policy

Thank you for visiting (the “Website”) and reviewing the Surgical Innovation Associates, Inc. (“Surgical Innovation Associates,” “we,” “us,” “our”) Privacy Policy (“Privacy Policy”). Your privacy is important to us. This Privacy Policy states how we handle the personal information we, or our service providers, collect in connection with your use of the Website and how we use and disclose that information.  This Privacy Policy applies to information collected by SIA through the Website or Web property (including, for example, a mobile Web site or application). This Privacy Policy does not describe information collection practices on other sites, including those linked to or from the Website. “Personal Information” for purposes of this Privacy Policy means information, alone or in conjunction with other information, that identifies, or reasonably may be used to identify, you, including, but not limited to, your name, address, phone number, or email address. Should you be asked to provide Personal Information when using this website, that information will only be used in accordance with this Privacy Policy.  This Policy is also subject to the provisions of our Website Terms and Conditions, available in our TERMS OF USE below, which are incorporated here by reference.  Please read this Privacy Policy carefully to understand our policies and practices regarding your information and how we will treat it. If you do not agree with our policies and practices, you should not use the Web Site. By accessing or using this Website, you accept and agree to be bound and abide by this Privacy Policy to the extent that it does not conflict with any applicable laws.  If you are under 18 years of age, your parent or guardian must agree to this Privacy Policy on your behalf by clicking to accept or agree when that option is made available.

This Privacy Policy may change from time to time. Your continued use of the Website after we make changes is deemed to be acceptance of those changes, so please check the Policy periodically for updates.

What Personal Information We Collect
We collect Personal Information directly from you when you interact with us on this Website, such as a submission of an inquiry or completion of a Contact Us form.  Information may include your name and email address.  We may combine the information you submit with other information we have collected from you, whether on- or offline, including, for example, your purchase history.  All data entered via the website is stored securely.

We collect industry standard log data about the browser and operating system you are using, the address of the external or internal page that referred you and your IP address at the time you submit an inquiry or contact us.  We may collect similar information, such as your device type and identifier, if you access the Website through a mobile device.

How We Use Your Personal Information
Surgical Innovation Associates does not use or sell, share or otherwise distribute your Personal Information with any third parties for their marketing purposes. Surgical Innovation Associates will share your Personal Information only in compliance with any applicable laws. Surgical Innovation Associates may use your Personal Information for its business purposes, such as to respond to your inquiries and fulfill your requests for information, products or services. Other business purposes include, but are not limited to:

  • If you have a business or professional relationship with Surgical Innovation Associates, to develop our business relationship with you;
  • To respond to employment inquiries and consider you for employment;
  • Provide you with marketing communications for products;
  • For our research and development efforts ;
  • For product safety, such as adverse event reporting or to communicate product safety information to you;
  • To enforce the Surgical Innovation Associates Terms and Conditions;
  • To affect the sale or transfer of business assets, to investigate legal issues, enforce our rights, protect our property, or protect the rights, property or safety of others, or as needed to support external auditing, compliance and corporate governance functions;
  • To allow third-parties to provide services to us such as information processing, order fulfillment, product delivery, customer data management, customer research and other similar services, in which case we require these third-parties to protect your information in the same manner as Surgical Innovation Associates is required to protect your information in accordance with any applicable law;
  • For other everyday business purposes such as processing of payment and account management, product development, contract management, website administration, order fulfillment, analytics, fraud prevention, corporate governance, reporting and legal compliance.

In addition, we use and disclose information collected through the Website as we believe to be necessary or appropriate: (a) as permitted by applicable law; (b) to comply with legal process; (c) to respond to requests from public and government authorities; (d) to enforce our terms and conditions; (e) to protect our operations; (f) to protect our rights, privacy, safety, or property, and/or that of you, or others; and (g) to allow us to pursue available remedies or limit the damages that we may sustain.

Cookies and Other Technology
A cookie is a small piece of information that is placed on your computer by your browser when you visit certain websites. You can find more about the use of cookies on

As you navigate through and interact with our Website, we use a type of cookie called a service cookie to help us make our website work efficiently for you. Our service cookie remembers your registration and login details as well as your IP address as you navigate between pages of our website.

We may also use analytic cookies for the purpose of measuring and analyzing Website usage and activity. An analytic cookie may use a web beacon, which is a transparent graphic image, to capture this usage data.

We may allow the use of third-party cookies to help us analyze certain online activities and improve the Website.  For example, these service providers may help us analyze visitor activity on the Website. We may permit these service providers to use cookies and other technologies to perform these services for Surgical Innovation Associates.  We do not share any Personal Information about you with these third-party service providers, and these service providers do not collect such information on our behalf. Our third-party service providers are required to comply fully with this Privacy Policy.

You can refuse to accept these cookies by following your browser’s instructions and adjusting your browser settings (normally found under ‘Options’ or ‘Tools’ or ‘Help’). However, the Website experience may be impacted or the full functionality of the Website may not be available to you. By using the Website with your browser settings adjusted to accept cookies, you consent to our use of cookies and other technologies as described in this Privacy Policy.

Disclosure to Subsequent Owner or Operator
If part or all of Surgical Innovation Associates is merged into or sold to another entity, the Personal Information we have about you may be transferred to a third party as part of that transaction. In the event of a merger or sale, your continued use of this site will signify your agreement to be bound by the Privacy Policy and other applicable terms of the subsequent owner or operator. If such a transition were to take place, we will try to ensure that no personally identifiable information that is transferred will be used or shared in a manner that is inconsistent with this Privacy Policy without your consent.

Children Under the Age of 13
The Website and its contents are not intended for children and we do not knowingly collect any Personal Information of anyone under the age of 13. If you are under the age of 13, please do not provide us with any Personal Information.  If we discover that a child under the age of 13 has provided us with personally identifying information, we will take steps to delete the information as soon as possible. If you believe your child is using our website, please contact us at so we can investigate.

Data Security
We use a combination of firewall barriers, encryption techniques, and authentication procedures, among others, designed to protect the security of your data and to protect our systems from unauthorized access.  Unfortunately, the transmission of information via the internet is not completely secure. Although we do our best to protect your personal information, we cannot guarantee the security of your Personal Information transmitted to our Website. Any transmission of personal information is at your own risk. We are not responsible for circumvention of any privacy settings or security measures contained on the Website.

Accessing and Correcting Your Information
You may contact us if you wish to view and/or correct the personal information that you provided to Surgical Innovation Associates via the Website, and we will use commercially reasonable efforts to accommodate your request. You may also contact us if you believe that any inaccurate or inappropriate information has been obtained or provided to others through your use of the Website.

Do Not Track
Our Website does not currently honor “Do Not Track” settings on web browsers and does not offer you the opportunity to request that Surgical Innovation Associates not track your use of the Website, except as may be stated otherwise in this Privacy Policy.

Users Outside the U.S.
This Website is intended for U.S. users only.  Information that is submitted to this Website will be collected, processed, stored, disclosed and disposed of in accordance with applicable U.S. law.

If you have any additional questions, please contact us at This website and its Privacy Policy are intended for visitors from the U.S. only.

Last updated July, 2020.

Merritt H. Spelina - Director of Customer Experience, Sales Analytics

Merritt leads customer experience and sales analytics at SIA following two decades thriving in roles that allow her to ethically serve companies and key corporate stakeholders. Merritt manages customer-facing sales operations and is working to establish best-in-class loyalty, customer engagement and internal reporting to drive business growth. With roles at Sientra (NYSE: SIEN), CBRE, Inc. and Lord Abbett & Co., LLC, Merritt has thrived within heavily-regulated fields while continuing to drive customer acquisition, retention, and revenue generation.

Nolan Karp, MD, FACS

Dr. Karp is a Professor of Plastic Surgery at NYU School of Medicine, Vice Chair of Clinical Operations at Hansjörg Wyss Department of Plastic Surgery, and Chief of Plastic Surgery and Director of the Breast Service at NYU-Tisch Hospital. He specializes in breast and body contouring plastic surgery and has extensive experience in all areas of breast surgery. He has authored over 10 chapters and 100 peer-reviewed papers, with particular focus on 3D scanning to plan and follow plastic surgery of the breast, and internal support for aesthetic and reconstructive breast surgery.

Todd Cruikshank, MBA - Chief Operating Officer

Todd has served as COO of SIA since 2016 and has nearly 15 years of experience developing and implementing operational strategies for healthcare companies. Todd previously operated at Baxalta within the Office of the CEO (acquired by Shire) and Baxter Healthcare (NYSE:BAX) holding positions of increasing responsibility in marketing, business intelligence and analytics within the Bioscience division focused on plasma-derived therapies for rare and orphan diseases. Todd has a B.A. degree in English from Illinois Wesleyan University and an M.B.A. from Northwestern Kellogg School of Management where he was a distinguished Zell Fellow.

John Slump, Chief Financial Officer

John is a serial entrepreneur who co-founded three medical device companies and brings 15 years of operating CFO experience to SIA. John was most recently CFO/Co-Founder of Attune Medical, manufacturer of a novel patient temperature management device with scaling global sales. Prior to that, John co-founded Farapulse (formerly known as Iowa Approach), a company pioneering a disruptive atrial fibrillation ablation technology funded by Boston Scientific (NYSE: BSX) and several venture capitalists. Previously, John was CFO/Co-Founder of Corvida Medical, a device he invented and commercialized to enable safer delivery of chemotherapy medications. John holds multiple patents and received a Bachelor’s Degree in Finance from University of Iowa.

Nelson Torres, PhD Director, Regulatory and Quality Affairs

Nelson is responsible for maintaining SIA’s Quality Management System and authoring regulatory submissions. He previously led regulatory and quality efforts at SA Scientific supporting diagnostic devices for infectious diseases and supporting the organization’s ISO 13485 compliant Quality Management System. Most recently, he led regulatory efforts for the pre-market notification of Fresenius Kabi’s DXT Data Management System. Nelson graduated with a BS in Biology and a PhD in Biomedical Engineering from the University of Texas at San Antonio.

Michele Hilmer Director, Clinical Affairs

Michele brings over thirty years of diverse pharmaceutical and device clinical trial expertise to SIA and oversees both ongoing global post-market studies and a first-in-class U.S.-based Investigational Device Exemption (IDE) study of breast reconstruction. Her previous work includes positions with the DOD, research sites, CROs, and sponsor companies. She is spearheading the planning and development of upcoming clinical trials and will oversee operations to ensure trial conduct adheres to GCP guidelines and FDA regulations.

Jason O’Hearn, Chief Commercialization Officer

Jason has 27 years of experience and a proven track record of developing and leading successful commercial organizations in plastic surgery, and he is now focused on taking SIA from a best-in-class clinical company to a first-in-class commercial company. He previously held executive roles of increasing responsibility within Sientra (NYSE: SIEN) and Mentor Corporation WW LLC, a division of Johnson & Johnson (NYSE: JNJ). During his tenure at these companies he led the Sales, Marketing, Professional Education, KOL Management and Clinical groups. He held these responsibilities globally – including both the introduction of new brands and the growth of market-leading devices in reconstructive and aesthetic surgery.

Hilton Becker, MD, FACS, FRCS

Dr. Becker is a renowned voice in plastic surgery, having invented multiple marketed products, lectured all over the world on his surgical techniques, and published more than 50 articles in medical literature. He primarily operates at his private practice in Boca Raton, FL, while also serving as Affiliate Associate Professor at FAU College of Medicine and Volunteer Faculty at Cleveland Clinic, Florida, Department of Plastic Surgery. His primary clinical and research interests lie in cosmetic and reconstructive breast surgery.

John Kim, MD, FACS

Dr. Kim is the Clinical Director of the Northwestern University Feinberg School of Medicine’s Division of Plastic Surgery and a nationally recognized leader in innovations in plastic and breast surgery. He sits on the Editorial Board for the Annals of Plastic Surgery and his work has been featured in national media outlets, including ABC News and the Chicago Sun-Times. Dr. Kim has given over 100 lectures and Grand Rounds presentations on new techniques in plastic surgery and has published more than 100 articles and chapters in the plastic surgery literature and holds several patents on novel medical devices.

Josh Vose, MD, MBA - CEO

Josh is responsible for the strategic direction of SIA, leading the team, and many things in between. His career in medtech began as an undergrad at Georgia Tech and continued through medical training at the Medical College of Georgia, general surgery training at Beth Israel Deaconess Medical Center, and the Sloan School of Management at MIT. Professionally, Josh has spent much of his career in early-stage, scaling ventures, and particularly in breast oncology and reconstruction, first at PEAK Surgical (creators of the PlasmaBlade family of devices) and then at Medtronic, following PEAK’s acquisition. He has authored numerous peer-reviewed publications, led key engagements with FDA, and tirelessly endeavors to raise the standard of care in healthcare and surgery through innovation.

Mark Kuzycz, MD, FACS

Dr. Kuzycz is Chairman of the Department of Surgery and Trauma Surgery at Aurora Medical Center. He joined Aurora when they acquired the multidisciplinary group that he built from a solo practice in general surgery. His practice focuses on hernia surgery ranging from uncomplicated repairs to complex abdominal wall reconstruction, and he is consistently in the 95th percentile for surgical volume in the country. He has served as consultant and advisor to companies from start-up to Fortune 500 level, and has lectured to +1,000 peers on national and international stages.

Albert Losken, MD, FACS

Dr. Losken is a Professor of Plastic Surgery at Emory University Hospital and has a busy clinical practice with a focus on breast reconstruction and abdominal wall hernia repair. He is devoted to patient care and to advancing techniques and technology to improve outcomes. His contributions to the field include over 170 scientific articles and numerous book chapters focusing on reconstructive and aesthetic surgery.

Mark Sicso, MD, FACS

Dr. Sisco is Chief of Plastic Surgery at NorthShore University HealthSystem in Evanston, IL and Clinical Associate Professor of Surgery at University of Chicago. His practice focuses on breast reconstruction and aesthetic surgery of the face and body. As an avid researcher, he has produced over 40 peer-reviewed articles and presentations, and performed pioneering laboratory research on scar formation and healing.

Ryan Egeland, MD, PhD

Dr. Egeland is a multidisciplinary medical device executive who recently joined Cardiovascular Systems, Inc (Nasdaq: CSII) as Vice President of Medical Affairs after roles in marketing, medical affairs, and business development at Medtronic. Prior to this, he trained as a plastic/reconstructive surgeon at Northwestern Memorial Hospital after receiving an MD with honors from Harvard Medical School. He also holds a PhD in biochemistry and engineering from the University of Oxford, where he also got his MBA as a Rhodes Scholar.

Robert Hombach

Robert Hombach is a global financial and operations executive with extensive experience in biopharma and medical devices. He recently retired after a 27-year career at Baxter and Baxalta, where he served as EVP CFO/COO. Bob is now on the Board of several public companies, including BioMarin and Aptinyx, and serves on the Board of several private start-up companies in the healthcare space.

John Vacha

John is the Managing Partner of MVC Advisors, LLC which is focused on providing C-Level consulting services. He has 20+ years of med-tech CEO & CFO experience, including both VC-backed startup and publicly traded companies. His last full-time CEO role was with Intact Medical, a breast-focused diagnostic device company that was successfully sold to Medtronic in late 2016.

Ordering Inquiry